Axitan

Biotechnology Research • Stevenage, England, United Kingdom • 11-20 Employees

Company overview

Headquarters	Arlington Business Park, 1 Arlington Court, Stevenage , SG1 2FS, GB
Website	axitan.com
NAICS	541714
SIC	873
Employees	11-20
Socials

Key Contacts at Axitan

Alfred Zimmerman

Chief Executive Officer

Alan Temple

Member Board Of Directors

Kane Miller

Managing Director

Gonzalo Prat

Vp Of Sales

Axitan Email Formats

Axitan uses 4 email formats. The most common is {first initial}.{last name} (e.g., j.doe@axitan.com), used 47.4% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@axitan.com	52.7%
{first name}.{last name}	john.doe@axitan.com	26.3%
{first initial}	j@axitan.com	21.1%

About Axitan

Axitan is a UK biotech company focused on eliminating antibiotics from animal feed and improving productivity. It is developing a library of endolysins, and associated products, capable of targeting those pathogens that impact livestock farming historically managed through antibiotic supplements in animal feed and, in so doing, improve productivityyields. Its focus forms part of wider WHO One Health initiative to combat the threat posed by antimicrobial resistance caused by the overuse of antibiotics, animals accounting for two thirds of the antibiotics consumed globally each year. In October 2022, Axitan achieved US FDA GRAS (“Generally Recognised As Safe”) status for the algal biomass ingredient used in its first product, FORC3®, which promotes healthy growth in poultry by targeting the pathogen Clostridium perfringens that causes $6b of economic loss each year to the poultry industry. Axitan has operations in the UK and US.

Axitan revenue & valuation

Annual revenue	$1,283,325
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$4,200,000
Total funding	No funding